Literature DB >> 9819106

An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle.

R D Maw1, M Reitano, M Roy.   

Abstract

Our aim was to determine country-specific attitudes and perceptions of patients with genital warts and to understand the psychosexual impact of the disease and its treatment. We used a standardized discussion guide to interview patients with genital warts in Canada, France, Germany, the UK, and the USA about their perceptions and concerns regarding the diagnosis, treatment, and psychosexual impact of the disease. Interviews were conducted in person and lasted approximately 30 min. The study group included 80 men and 86 women with genital warts. Forty-seven per cent were currently undergoing treatment. Overall, 49% of the men had first consulted a general or family practitioner, and 52% of the women had first consulted a gynaecologist. Although all the patients eventually consulted a physician about their warts, one-third delayed seeing a doctor because they thought the condition would resolve on its own or that the problem was not serious. Most patients reported that treatment was associated with pain, discomfort, and embarrassment. Sixty per cent of patients experienced a recurrence after initial clearance with treatment. More than 80% stated that they had had little or no involvement in the selection of treatment. Globally, 52% of men and 61% of women were 'quite concerned' or 'very concerned' about having genital warts, although there were significant variations by country. Approximately two-thirds of patients had made lifestyle changes regarding sexual relationships. In addition, two-thirds believed that there were risks associated with having genital warts; the most common risk identified was a link to cancer (cervical and unspecified). A high level of anxiety is associated with the diagnosis and treatment of genital warts. Patients with genital warts require understanding and an acknowledgement of their concerns. A better understanding of the psychosexual aspect of the disease by health-care providers is pivotal to effective disease management and patient counselling.

Entities:  

Mesh:

Year:  1998        PMID: 9819106     DOI: 10.1258/0956462981921143

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  32 in total

1.  European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts.

Authors:  G von Krogh; C J Lacey; G Gross; R Barrasso; A Schneider
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

2.  Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts.

Authors:  Manjula Singh; Deepshi Thakral; Narayan Rishi; Hemanta Kumar Kar; Dipendra Kumar Mitra
Journal:  Virusdisease       Date:  2017-06-13

Review 3.  A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus.

Authors:  Yiling Jiang; Aline Gauthier; Maarten J Postma; Laureen Ribassin-Majed; Nathalie Largeron; Xavier Bresse
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

4.  Quality of life of homosexual males with genital warts: a qualitative study.

Authors:  Gitte Lee Mortensen; Helle K Larsen
Journal:  BMC Res Notes       Date:  2010-11-04

5.  Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011.

Authors:  Eloisa Llata; Mark Stenger; Kyle Bernstein; Sarah Guerry; Roxanne Kerani; River Pugsley; Preeti Pathela; Irina Tabidze; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2014-02       Impact factor: 2.830

Review 6.  Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  Role of histological findings and pathologic diagnosis for detection of human papillomavirus infection in men.

Authors:  Nikki S Vyas; Christine M Pierce Campbell; Rahel Mathew; Martha Abrahamsen; Kaisa Van der Kooi; Drazen M Jukic; Mark H Stoler; Luisa L Villa; Roberto Carvalho da Silva; Eduardo Lazcano-Ponce; Manuel Quiterio; Jorge Salmeron; Bradley A Sirak; Donna J Ingles; Anna R Giuliano; Jane L Messina
Journal:  J Med Virol       Date:  2015-05-06       Impact factor: 2.327

8.  The quality of life of patients with genital warts: a qualitative study.

Authors:  Gitte Lee Mortensen; Helle K Larsen
Journal:  BMC Public Health       Date:  2010-03-07       Impact factor: 3.295

9.  Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

Authors:  Joakim Dillner; Susanne K Kjaer; Cosette M Wheeler; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricia García; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Matti Lehtinen; Marc Steben; F Xavier Bosch; Elmar A Joura; Slawomir Majewski; Nubia Muñoz; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Roger Maansson; Shuang Lu; Scott Vuocolo; Teresa M Hesley; Eliav Barr; Richard Haupt
Journal:  BMJ       Date:  2010-07-20

Review 10.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.

Authors:  Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.